A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
The bacterial cell wall is a rigid peptidoglycan structure that surrounds the plasma membrane, providing shape and protection. Gram-positive and gram-negative bacteria have fundamentally different wall architectures: gram-positive cells have a thick peptidoglycan layer with teichoic acids, while gram-negative cells have a thin peptidoglycan layer sandwiched between an inner and outer membrane.
Examine electron micrographs of bacterial cell sections and gram-stained preparations. Visualize the difference in thickness and staining patterns between gram-positive and gram-negative cells.
The gram stain does not reveal the true structure of the cell wall—it only identifies chemical differences that affect dye retention. Peptidoglycan is not a simple polymer but a cross-linked mesh of peptide and sugar chains.
From your study of basic bacterial cell structure, you know that bacteria are bounded by a plasma membrane that controls what enters and exits the cell. But unlike animal cells, most bacteria face an additional challenge: they live in environments where osmotic pressure would burst an unprotected membrane. The cell wall solves this problem by providing a rigid exoskeleton outside the plasma membrane. The primary structural component of this wall is peptidoglycan (also called murein), a mesh-like polymer made of long sugar chains cross-linked by short peptide bridges. The sugar backbone alternates between two modified glucose molecules — N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) — connected by glycosidic bonds. Peptide side chains extending from NAM residues form cross-links between adjacent sugar strands, creating a single enormous bag-shaped molecule that surrounds the entire cell.
The most important architectural distinction in bacteriology divides bacteria into two groups based on their wall structure, revealed by the Gram stain. Gram-positive bacteria have a thick peptidoglycan layer (20–80 nm, many layers deep) that sits directly outside the plasma membrane. Embedded within and attached to this thick mesh are teichoic acids — negatively charged polymers of glycerol phosphate or ribitol phosphate that extend through and beyond the peptidoglycan. Teichoic acids contribute to cell wall rigidity, help regulate ion movement, and play roles in cell division and adhesion. When crystal violet dye is applied during Gram staining, the thick peptidoglycan traps the dye-iodine complex even after alcohol decolorization, producing the characteristic purple color.
Gram-negative bacteria have a fundamentally different architecture. Their peptidoglycan layer is thin (just 1–3 layers, about 2–7 nm) and is sandwiched in a compartment called the periplasmic space between the inner (plasma) membrane and an additional outer membrane. This outer membrane is a lipid bilayer with a unique composition: its outer leaflet contains lipopolysaccharide (LPS), a large molecule with a lipid A anchor, a core polysaccharide, and a variable O-antigen chain. LPS creates a formidable permeability barrier that excludes many antibiotics and detergents, and its lipid A component is a potent endotoxin that triggers strong immune responses during infection. Small hydrophilic molecules cross the outer membrane through porins — barrel-shaped channel proteins. During Gram staining, the alcohol wash dissolves the outer membrane and washes the crystal violet out of the thin peptidoglycan, so these cells take up the pink counterstain (safranin) instead.
Understanding this architectural difference has direct medical significance. Many antibiotics target peptidoglycan synthesis — penicillin and other β-lactams, for example, inhibit the transpeptidase enzymes that form the peptide cross-links. These drugs are generally more effective against gram-positive bacteria because the thick, exposed peptidoglycan is readily accessible. Gram-negative bacteria are inherently more resistant to many antibiotics because the outer membrane acts as an additional barrier that drugs must penetrate before reaching their peptidoglycan target. This is why gram-negative infections are often harder to treat, and why the structural differences first revealed by a simple staining technique in 1884 remain central to clinical microbiology today.